Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Lipids Année : 2016

Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry

Résumé

Oxygenated lipid mediators released from non-enzymatic peroxidation of polyunsaturated fatty acids (PUFA) are known to have functional roles in humans. Notably, among these lipid mediators, isoprostanes molecules are robust biomarkers of oxidative stress but those from n-3 PUFA are also bioactive molecules. In order to identify and assess the isoprostanes, the use of mass spectrometry (MS) for analysis is preferable and has been used for over two decades. Gas chromatography (GC) is commonly coupled to the MS to separate the derivatized isoprostanes of interest in biological samples. In order to increase the accuracy of the analytical performance, GC-MS/MS was also applied. Lately, MS or MS/MS has been coupled with high-performance liquid chromatography to assess multiple isoprostane molecules in a single biological sample without derivatization process. However, there are limitations for the use of LC-MS/MS in the measurement of plasma isoprostanes, which will be discussed in this review.
Fichier principal
Vignette du fichier
2016 Lee et al., Assessment of Isoprostanes.pdf (40.33 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01784397 , version 1 (06-12-2019)

Identifiants

Citer

Yiu Yiu Lee, Jean-Marie Galano, Camille Oger, Claire Vigor, Guillaume Reversat, et al.. Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry. Lipids, 2016, 51 (11), pp.1217 - 1229. ⟨10.1007/s11745-016-4198-x⟩. ⟨hal-01784397⟩
205 Consultations
178 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More